with double-digit earnings growth, and investment in exciting areas of science, including antibody drug conjugates and cell therapies, that lay the foundations for long-term success.
Side effects, COVID-19 vaccinesLong-termHeterogenousBangladeshAssessment of side effects associated with COVID-19 vaccination is required to monitor safety issues and acceptance of vaccines in the long term. We found a significant knowledge gap in the safety profile of COVID-19 vaccines in ...
Caution should be exercised when considering the coadministration of BREZTRI with long-term ketoconazole and other known strong CYP3A4 Inhibitors. Adverse effects related to increased systemic exposure to budesonide may occur If paradoxical b...
In September 2023, Kiev called upon EU member states to deport alleged Ukrainian “draft dodgers” – something which European countries have largely refused to do so far – while in August, Zelensky ordered a full review of all mobilization exemptions granted by Military Medical Commissions (MMCs)...
Caution should be exercised when considering the coadministration of BREZTRI with long-term ketoconazole and other known strong CYP3A4 Inhibitors. Adverse effects related to increased systemic exposure to budesonide may occur If paradoxical bronchospasm occu...
The safety and tolerability of LYNPARZA plus abiraterone was in line with that observed in prior clinical trials and the known profiles of the individual medicines. At the time of this updated analysis, there were no...
Caution should be exercised when considering the coadministration of BREZTRI with long-term ketoconazole and other known strong CYP3A4 Inhibitors. Adverse effects related to increased systemic exposure to budesonide may occur If ...
This commonly used gene assay provides a recurrence score (RS) between 0 and 100, with lower scores indicating a smaller risk of recurrence and thus a less likely benefit from adjuvant chemotherapy relative to its side effects. Patients with an RS between 11 and 25 were randomly assigned to ...
From the beginning of 2023, the growth of the branded market in myasthenia gravis in the United States, but also around the world has been very dynamic. And this is accelerating with the arrival of new clinical options for patients. So we have mentioned in my prepared remarks that the growt...
These learnings have been taken into the company’s wider strategy of balancing innovation and market access while improving access to therapies and patient health in lower middle-income countries – and helping drive long-term sustainable growth in the process. While the company has invested in em...